U.S. Endoscope Reprocessing Market – Industry Trends and Forecast to 2029

Market Analysis and Size

As per the American Cancer Society’s estimates, the number of new colorectal cancer cases in the United States by the end of 2018 reached 97,220, while the number of new cases of rectal cancer reached 43,030. This high incidence indicates the demand for screening by colonoscopic devices or sigmoidoscopic devices, which further drives the growth of the market.

Data Bridge Market Research analyses that the endoscope reprocessing market which was USD 1.85 billion in 2021, would rocket up to USD 3.45 billion by 2029, and is expected to undergo a CAGR of 8.10% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Market Definition

Endoscopes are used to identify, diagnose, and treat malignant gastrointestinal (GI) disorders at an early stage. However, because of their complicated construction and wide range of applications in medical operations, the risk of infection transmission linked with endoscopes is usually considerable. As a result, numerous countries' health organisations have developed tight endoscope reprocessing processes in order to increase safety and prevent infection spread. According to these regulations, endoscopes must go through several phases of thorough cleaning and disinfection before being used on patients. AERs (automated endoscope reprocessors) are also being introduced by numerous manufacturers for consistent, accurate, and cost-effective operation. By exposing the exterior surfaces and inner channels of reusable endoscopes to high-level disinfectant or liquid chemical sterilant solutions, AERs help destroy bacteria.

Endoscope Reprocessing Market Dynamics

Drivers

• Increasing prevalence of digestive diseases

The increased prevalence of digestive diseases as a result of changing lifestyles has led to an increase in endoscopic examinations, boosting the market. In the forecast period of 2029, the rising prevalence of launching innovative products for patient safety will generate new opportunities that will impact the endoscope reprocessing market growth. In April, Advanced Sterilization Products (ASP) received 510(k) certifications for their ASP AEROFLEX AER automatic endoscope reprocessor. It is the quickest, with a cycling time of 22 minutes. As a new product, it will result in increased revenue and the expansion of the product portfolio.

• Increasing endoscopic gadgets

The rising incidence of endoscopy-related infections, increased hospital investments in endoscopy tools, and the rising number of disorders that require endoscopic operations are all driving the endoscope reprocessing market forward. Endoscopic gadgets are being used more frequently in illness detection and therapy. The increasing prevalence of disorders detectable by endoscopy has raised demand for these devices.

• Rising desire for procedures

The desire procedures result in a speedier recovery, fewer post-surgery infections, less discomfort, less scarring, better bleeding control, and higher accuracy is expected to drive up demand for various endoscopic devices. Major industry participants are working on getting new items approved to grow their product portfolio. For example, Advanced Sterilization Products' ASP AEROFLEX Automatic Endoscope Reprocessor was approved by the US Food and Drug Administration in April 2019. As a result of the increasing number of endoscopic reprocessing devices on the market, the industry is expected to increase rapidly.

Opportunities

The demand for flexible endoscopes to identify and treat cancer and GI illnesses is being driven by the expanding paediatric population, which is more vulnerable to targeted diseases. Endoscopy devices are also utilised to explore atypical symptoms such as dysphagia, diarrhoea, weight loss, heartburn, and stool blood, which is driving the development of endoscope reprocessing to reduce infection risk. Furthermore, health organisations are implementing facility-level training programmes to help healthcare facilities achieve consistent, high-quality endoscope reprocessing. This, together with a growing focus on enhancing reprocessing criteria, is expected to propel the market forward.

Restraints/Challenges

Dearth of skilled professionals to carry out endoscopic procedures and the concerns regarding the safety of reprocessed instruments are the factors expected to hinder market growth.

This endoscope reprocessing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the endoscope reprocessing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Endoscope Reprocessing Market

During the present COVID-19 epidemic, when sterilisation is a top priority, the importance of automated endoscope reprocessors has increased, as these reprocessors have become an integral part of endoscopic surgery preparations. As a result, they've become more popular in hospitals and clinics. Class II devices and automated endoscope reprocessors are in high demand because of their numerous advantages. Furthermore, the US Food and Drug Administration (US FDA) continues to approve new automated endoscope reprocessors. For example, Cantel Medical recently reported that its revolutionary automated endoscope preprocessor has achieved 510 (k) clearance. As a result of the factors mentioned above, the market is predicted to increase significantly over the forecast period.

Recent Development

• In February 2020, Olympus Corporation of the Americas and Amplifire have teamed up to offer technicians a new digital learning platform to learn about endoscope reprocessing. The Olympus TJF-Q180V duodenoscope, a complicated medical endoscope used for endoscopic retrograde cholangiopancreatography, will be reprocessed by the new digital learning platform (ERCP).
• In January 2020, In the United States, PENTAX Medical introduced the DEC HD Duodenoscope, an improved, high-definition duodenoscope with various disposable components for unit reprocessing, including the sterile distal cap and elevator lever.

U.S. Endoscope Reprocessing Market Scope

The endoscope reprocessing market is segmented on the basis of products, modality, process type, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Products

• Equipments
• Consumables

 Modality

• Bench Top Endoscopic Reprocessors
• Stand- Alone Endoscopic Reprocessors

Process Type

• Automated Cleaning Disinfectants
• Manual Cleaning Solutions

 End-user

• Hospitals
• Ambulatory Surgical Centres (ASCS)
• Clinics
• Diagnostic Centres
• Others

Competitive Landscape and Endoscope Reprocessing Market Share Analysis

The endoscope reprocessing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to endoscope reprocessing market.

Some of the major players operating in the endoscope reprocessing market are:

• Cantel Medical (US)
• ASP (US)
• Olympus Corporation (Japan)
• Ecolab (US)
• STERIS (Ireland)
• Getinge AB (Sweden)
• Wassenburg Medical (Netherlands)
• CONMED Corporation (US)
• Belimed AG (Switzerland)
• Endo-Technik W. Griesat (Germany)
• Custom Ultrasonics.com (US)
• Steelco S.p.A. (Italy)
• BES Rehab Ltd (UK)
• ARC Group of Companies Inc. (Canada)
• Metrex Research, LLC. (Canada)
• Richard Wolf GmbH (Germany)
• MEDALKAN (Greece)
• Micro-Scientific, LLC (US)
• Borer Chemie AG (Switzerland)
• Tuttnauer (Netherlands)
• ATMS (Canada)
• Summit Imaging, Inc. (US)
• Medonica Co. LTD (South Korea)
• SHINVA MEDICAL INSTRUMENT CO. LTD (China)
• Medical Devices Group Srl (Italy)

SKU-53058